New drug BLKR201 put to the test in healthy volunteers
NCT ID NCT07501039
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing whether a new drug called BLKR201 is safe for people. About 128 healthy adults will take either the drug or a placebo and stay at a research clinic for several days. Researchers will monitor side effects, measure how the drug moves through the body, and check if food changes its absorption. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
RECRUITINGLincoln, Nebraska, 68502, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••